Sep 2026· Experimental and Therapeutic Medicine· Vol 32, pp. 1-15· 0 citations· 102 references
Medicine
TL;DR
Although preclinical studies have validated ASF1A as a promising prognostic biomarker and therapeutic target, relevant clinical trials supporting its clinical application remain absent.
Abstract
Anti-silencing function 1A (ASF1A) is an evolutionarily conserved histone H3/H4 chaperone that mediates nucleosome assembly, DNA replication and DNA damage repair. Beyond these canonical biological functions, aberrant ASF1A expression facilitates disease progression by triggering epigenetic dysregulation in multiple malignant tumors (including leukemia, breast, liver and gastrointestinal cancers) and non-neoplastic disorders (such as atherosclerosis and embryonic developmental defects). Its context-dependent biological effects are mediated via oncogenic signaling cascades and crosstalk between metabolism and epigenetics. Although preclinical studies have validated ASF1A as a promising prognostic biomarker and therapeutic target, relevant clinical trials supporting its clinical application remain absent. This review systematically summarizes the molecular features, pathogenic mechanisms and translational application potential of ASF1A.
The biological functions of the NSD family of histone methyltransferases are summarized, their oncogenic mechanisms in solid tumors are discussed, and recent progress in therapeutic targeting is highlighted.
Y. Zhang, Andrew Plenn, Joey Sun et al.· International Journal of Mol...· 0 citations
Abstract Ribosomal protein S3 (RPS3) is an essential structural component of the 40S ribosomal subunit, yet growing evidence highlights crucial extraribosomal roles in genome maintenance, cell-cycle control, and immune signaling. Dysregulation of RPS3 contributes to diverse human disorders, including cancer, inflammato...
Joeline Dreik, M. Al Ali, Jalil Daher et al.· Bioscience Reports· 0 citations
Linker histone H1 has traditionally been regarded as a structural scaffold that stabilizes higher-order chromatin organization. Recent evidence, however, indicates that H1 variants are dynamic chromatin regulators with variant-specific functions in cancer. Among them, H1.2, encoded by H1-2 (formerly HIST1H1C), has emer...
This review comprehensively summarizes the multifaceted roles of major histone modifications, including acetylation, methylation, ubiquitination, phosphorylation, and emerging metabolism-linked acylations, in governing critical DNA-templated processes such as replication, transcription, and the DNA damage response.
Ling-Li Wang, Shi-Ying Li, Xiao-Yan Hu et al.· Precision Clinical Medicine· 0 citations
This framework positions CARM1 as a context-conditioned signal-to-chromatin translator rather than a uniformly druggable oncogene, and may offer the most tractable route to clinical translation.
Lu-Yao Zhu, Ya-Jie Liang, Qi-Qi Mao et al.· Biochimica et biophysica act...· 0 citations
Cancer progression is driven by coordinated dysregulation of signaling and gene-expression programs that sustain multiple hallmarks of malignancy. Eukaryotic initiation factor 4E (eIF4E) has emerged as an important determinant of this translational reprogramming by preferentially enhancing the synthesis of proteins tha...
Magdalene Eno Udobi, P. Effiong, Sumon Roy et al.· Critical reviews in oncology...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.
